Table 1

CRP values across characteristics of the study population

NP (n=646)CHARLS (n=8555)P value†
Median (IQR)*P value†Median (IQR)*
Age<0.001<0.001
 45–600.6 (0.3 to 1.2)0.9 (0.5 to 1.7)
 ≥600.8 (0.4 to 1.8)1.1 (0.6 to 2.1)
Sex0.0110.003
 Men0.6 (0.3 to 1.3)1.0 (0.5 to 2.0)
 Women0.8 (0.4 to 1.7)0.9 (0.5 to 1.8)
Education0.0040.316
 Illiterate0.9 (0.4 to 1.8)1.0 (0.5 to 2.0)
 Literate0.6 (0.3 to 1.3)0.9 (0.5 to 1.9)
Marital status0.495<0.001
 Married0.7 (0.3 to 1.5)0.9 (0.5 to 1.9)
 Non-married0.7 (0.4 to 1.7)1.1 (0.6 to 2.4)
Smoking0.4670.041
 Current smokers0.6 (0.3 to 1.4)1.0 (0.5 to 2.0)
 Non-current smokers0.7 (0.4 to 1.6)0.9 (0.5 to 1.9)
Alcohol consumption0.0010.635
 Regular drinkers0.5 (0.3 to 1.1)0.9 (0.5 to 1.9)
 Non-regular drinkers0.8 (0.4 to 1.6)1.0 (0.5 to 1.9)
BMI<0.001<0.001
 Underweight (<18.5)0.5 (0.2 to 1.4)0.8 (0.5 to 1.9)
 Normal weight (18.5–24.99)0.6 (0.3 to 1.1)0.8 (0.5 to 1.7)
 Overweight (25–29.99)1.2 (0.6 to 2.3)1.2 (0.7 to 2.3)
 Obese (≥30)1.6 (1.0 to 4.4)1.9 (0.9 to 3.3)
Self-rated health0.071<0.001
 Good0.6 (0.3 to 1.7)0.9 (0.5 to 1.8)
 Average0.7 (0.3 to 1.5)0.9 (0.5 to 1.8)
 Poor0.8 (0.4 to 1.5)1.0 (0.6 to 2.1)
 Very poor1.0 (0.5 to 2.3)1.1 (0.6 to 2.3)
Health status‡0.002<0.001
 Healthy0.5 (0.3 to 1.3)0.8 (0.5 to 1.7)
 Unhealthy0.8 (0.4 to 1.6)1.0 (0.5 to 2.0)
  • Missing values: NP: 1 missing in health status. CHARLS: 2 missing in age, 7 missing in sex, 4 missing in education,1 missing in smoking, 3 missing in alcohol consumption, 1191 missing in BMI, 65 missing in health status.

  • *Median (Interquartile range, IQR).

  • †Analysis of variance (ANOVA) was applied to compare the mean of log-transformed values of CRP.

  • ‡Health status: Unhealthy: Self-reported moderate to severe symptoms in the last month or used antihypertensive or antidiabetic medications (NP); Had been diagnosed by a doctor with any disease or often suffered from any pain currently (CHARLS). Healthy: no such report.

  • BMI, body mass index; CHARLS, China Health and Retirement Longitudinal Study; CRP, C-reactive protein; NP, Nanping project.